TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $319 | -99.4% | 21,224 | +74.1% | 0.03% | +750.0% |
| Q2 2022 | $52,000 | -73.5% | 12,191 | -40.7% | 0.00% | -73.3% |
| Q1 2022 | $196,000 | -22.2% | 20,565 | +216.7% | 0.02% | -37.5% |
| Q2 2021 | $252,000 | -72.1% | 6,493 | -62.5% | 0.02% | -75.3% |
| Q4 2020 | $902,000 | +342.2% | 17,330 | +65.4% | 0.10% | +304.2% |
| Q2 2020 | $204,000 | -43.5% | 10,477 | -67.8% | 0.02% | -31.4% |
| Q4 2019 | $361,000 | +423.2% | 32,551 | +165.2% | 0.04% | +600.0% |
| Q3 2019 | $69,000 | -67.3% | 12,273 | -76.2% | 0.01% | -54.5% |
| Q4 2018 | $211,000 | +263.8% | 51,570 | +399.5% | 0.01% | +175.0% |
| Q3 2018 | $58,000 | -88.8% | 10,325 | -71.8% | 0.00% | -85.7% |
| Q1 2018 | $520,000 | +37.6% | 36,592 | -20.5% | 0.03% | +40.0% |
| Q4 2017 | $378,000 | +58.8% | 46,055 | +129.0% | 0.02% | +66.7% |
| Q3 2017 | $238,000 | – | 20,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |